Multifocal Motor Neuropathy Clinical Trial
Official title:
A Randomized, Double-Blind, Placebo Controlled, Cross-over Study of the Effectiveness of Immune Globulin Intravenous (Human), 10% (IGIV, 10%) for the Treatment of Multifocal Motor Neuropathy
The purpose of the study is to evaluate the efficacy (effect on grip strength and disability) and safety/tolerability of IGIV, 10% in subjects with Multifocal Motor Neuropathy.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06040567 -
Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
|
||
| Not yet recruiting |
NCT02885259 -
HyQvia in Multifocal Motor Neuropathy
|
N/A | |
| Active, not recruiting |
NCT01655394 -
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
|
N/A | |
| Recruiting |
NCT05988073 -
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
|
||
| Active, not recruiting |
NCT05225675 -
A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults With Multifocal Motor Neuropathy
|
Phase 2 | |
| Completed |
NCT02556437 -
Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)
|
Phase 2 | |
| Completed |
NCT02111590 -
Immunoglobulin Dosage and Administration Form in CIDP and MMN
|
N/A | |
| Completed |
NCT00268788 -
Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
|
Phase 2 | |
| Completed |
NCT02121678 -
Effect of Resistance and Aerobic Exercise in CIDP or MMN
|
N/A | |
| Completed |
NCT01827072 -
Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.
|
Phase 3 |